AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding AC Immune SA changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 41 | 42 | +1 |
| Shares | 25.9M | 24.5M | −1.42M (−5.5%) |
| Value | $48.5M | $49.7M | +$1.27M (+2.6%) |
New holders (4)
Institutions that held AC Immune SA at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 30,690 | $62.3K | 0.00% |
| Goldman Sachs Group Inc | 10,369 | $21.0K | 0.00% |
| Two Sigma Securities, LLC | 10,085 | $20.5K | 0.00% |
| Advisor Group Holdings, Inc. | 251 | $509 | 0.00% |
Sold out (3)
Institutions that held AC Immune SA at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Platinum Investment Management Ltd | 739,342 | $1.38M |
| Lazard Asset Management LLC | 813 | $1.00K |
| SJS Investment Consulting Inc. | 200 | $374 |